Paper35947136
Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis.
Fekry B and 12 others. FASEB J, 2022. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. Papers, record 35947136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35947136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| ARNTL Transcription Factors | |
| Animals | |
| Carcinogenesis | |
| Cell Transformation, Neoplastic | |
| Liver | |
| Mice |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DK114037 | NIDDK NIH HHS | United States | R01DK114037 | PubMed and NIH |
Source NIH RePORTER
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16614707 | Expression profiling of cyclin B1 and D1 in cervical carcinoma. | Exp Oncol | 2006 | https://conductscience.org/library/papers/16614707 | PubMed |
| 2 | 29525529 | AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. | J Hepatol | 2018 | https://conductscience.org/library/papers/29525529 | PubMed |
| 3 | 21734724 | Cyclin D as a therapeutic target in cancer. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21734724 | PubMed |
| 4 | 18443477 | Arginine vasopressin in vasodilatory shock: effects on metabolism and beyond. | Curr Opin Anaesthesiol | 2008 | https://conductscience.org/library/papers/18443477 | PubMed |
| 5 | 19659896 | Experimental mouse models for hepatocellular carcinoma research. | Int J Exp Pathol | 2009 | https://conductscience.org/library/papers/19659896 | PubMed |
| 6 | 20876809 | Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. | Cancer Res | 2010 | https://conductscience.org/library/papers/20876809 | PubMed |
| 7 | 18802415 | The genetics of mammalian circadian order and disorder: implications for physiology and disease. | Nat Rev Genet | 2008 | https://conductscience.org/library/papers/18802415 | PubMed |
| 8 | 16353170 | Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy. | J Pathol | 2006 | https://conductscience.org/library/papers/16353170 | PubMed |
| 9 | 27166517 | Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer. | Elife | 2016 | https://conductscience.org/library/papers/27166517 | PubMed |
| 10 | 17300672 | Downregulated P1 promoter-driven hepatocyte nuclear factor-4alpha expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. | Pathol Int | 2007 | https://conductscience.org/library/papers/17300672 | PubMed |
| 11 | 25947066 | Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer. | J Transl Med | 2015 | https://conductscience.org/library/papers/25947066 | PubMed |
| 12 | 10051469 | Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. | Hepatology | 1999 | https://conductscience.org/library/papers/10051469 | PubMed |
| 13 | 15358634 | Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. | Carcinogenesis | 2005 | https://conductscience.org/library/papers/15358634 | PubMed |
| 14 | 22572382 | The responses of the hepatic and splanchnic vascular beds to vasopressin in rats. | Biomed Res | 2012 | https://conductscience.org/library/papers/22572382 | PubMed |
| 15 | 25747274 | β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis. | Gastroenterology | 2015 | https://conductscience.org/library/papers/25747274 | PubMed |
| 16 | 22383578 | Identification of a binding motif specific to HNF4 by comparative analysis of multiple nuclear receptors. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22383578 | PubMed |
| 17 | 19380369 | Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. | Int J Epidemiol | 2009 | https://conductscience.org/library/papers/19380369 | PubMed |
| 18 | 30454647 | Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. | Cell | 2018 | https://conductscience.org/library/papers/30454647 | PubMed |
| 19 | 11163178 | Mop3 is an essential component of the master circadian pacemaker in mammals. | Cell | 2000 | https://conductscience.org/library/papers/11163178 | PubMed |
| 20 | 20539819 | Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. | PLoS One | 2010 | https://conductscience.org/library/papers/20539819 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42309179 | Integrated multi-omic analyses reveal novel gene-metabolite relationships in human steatohepatitic hepatocellular carcinoma. | J Lipid Res | 2026 | https://conductscience.org/library/papers/42309179 | PubMed |
| 41582251 | Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41582251 | PubMed |
| 41554703 | Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41554703 | PubMed |
| 41465212 | The Circadian Modulators as Molecular Targets in Cancer-A Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465212 | PubMed |
| 41124076 | Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. | Cell Rep | 2025 | https://conductscience.org/library/papers/41124076 | PubMed |
| 40616824 | Circadian rhythm in gastrointestinal cancer: clinical applications and future perspectives. | Ann Med | 2025 | https://conductscience.org/library/papers/40616824 | PubMed |
| 39643860 | Overexpression of BMAL-1 is related to progression of urothelial carcinoma in arsenic exposure area. | Int Urol Nephrol | 2025 | https://conductscience.org/library/papers/39643860 | PubMed |
| 39061191 | Extracellular Vesicles, Circadian Rhythms, and Cancer: A Comprehensive Review with Emphasis on Hepatocellular Carcinoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39061191 | PubMed |
| 38890243 | RNA-Seq transcriptome profiling of Nile rat livers reveals novel insights on the anti-diabetic mechanisms of Water-Soluble Palm Fruit Extract. | J Appl Genet | 2024 | https://conductscience.org/library/papers/38890243 | PubMed |
| 38469551 | The role of circadian clock in regulating cell functions: implications for diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/38469551 | PubMed |
| 36473131 | Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD). | Oncotarget | 2022 | https://conductscience.org/library/papers/36473131 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35947136
GET https://conductscience.org/api/papers/v1/35947136/references?page=2